Drogas e Sistema Nervoso Periférico I

Neuropatias Tóxicas Induzidas por Drogas

Autores

  • Roger Gomes Reis
  • Acary Souza Bulle Oliveira

DOI:

https://doi.org/10.34024/rnc.1999.v7.10313

Palavras-chave:

Neuropatia periférica, toxicidade, drogas

Resumo

Continuamente aumenta nosso conhecimento sobre os mecanismos patofisiológicos das várias doenças e aumenta o número das drogas que podem ser usadas para tratá-las. Entretanto, muitas das drogas para o tratamento de doenças clínicas, incluindo as neurológicas, podem causar toxicidade sistêmica e disfunção neurológica. Os autores apresentam uma revisão da toxicidade sobre o sistema nervoso periférico induzida pelas diversas drogas em uso corrente.

Métricas

Carregando Métricas ...

Downloads

Não há dados estatísticos.

Referências

1. Le Witt PA, Forno LS. Peripheral neuropathy following amitriptyline overdose. Muscle Nerve, 8:723-724, 1985.
2. Ramilo O, Kinane BT, McCraken GH. Chloramphenicol neurotoxicity. Pediatr Infect J, 7:358-359, 1988.
3. Whisnatt JP, Estes ML, Kierland RR, Lambert EH. Chloroquine neuromyopathy. Proc Mayo Clin, 38:501-509, 1963.
4. Estes ML, Ewing-Wilson D, Chou SM, Mitsumoto H, Hanson M et al. Cloroquine neuromyotoxicity – clinical and pathologic perspective. Am J Med, 82:447-455, 1987.
5. Tegner R, Tomé FMS, Godou P. Morphological study of peripheral nerve changes induced by chloroquine treatment. Acta Neuropathol, 75:253-268, 1988.
6. Kuncl RW, Duncan G, Watson D, Alderson K, Rogowski MA et al. Colchicine myopathy and neuropathy. N Engl J Med, 316:1562-1568, 1981.
7. Riggs JE, Schochet SS, Gutmann L. Chronic human colchicine neuropathy and myopathy. Arc Neurol, 43:521-527. 1986.
8. Ansbacher LE, Bosch EP, Concilla PA. Dissulfiram neuropathy – a neurofilamentous distal axonopathy. Neurology, 32:424-428, 1982.
9. Nukada H, Pollock M. Dissulfiram neuropathy – a morphometric study of sural nerve. J Neurol Sci, 51-60, 1981.
10. Nair US, Le Brun M, Kass I. Peripheral neuropathy associated with ethambutol. Chest, 77:98-100, 1980.
11. Swift TR, Gross JA, Ward C, Crout BO. Peripheral neuropathy in epileptic patients. Neurology, 31:826-831, 1981.
12. Ramirez JA, Mendell JR, Warnolts R, Griggs RC. Phenytoin neuropathy – structural changes in the sural nerve. Ann Nerol, 19:162-167, 1986.
13. Raskin DM, Fischman PA. Pyrydoxine – deficiency neuropathy due to hydralazine. N Engl J Med, 273:1182-1187, 1965.
14. Ochoa J. Isoniazid neuropathy in man – quantitative electronmicroscope study. Brain, 93:831-846, 1970.
15. Jacobs JM, Miller RH, Whittle A, Cavanagh JB. Studies on the early changes of acute isoniazid neuropathy in the rat. Act Neuropathol, 47:85-96, 1979.
16. Schlaepfer WW, Hager H. Ultrastructural studies of INHinduced neuropathy in rats. Am J Pathol, 45:423-434, 1964.
17. Pamphlett RS, Mackenzie RA. Severe peripheral neuropathy due to lithium intoxication. J Neurol Neurosurg Psychiatry, 45:656-661, 1982.
18. Bradley WG, Bennett RK, Good P. Metronidazole neuropathy. Br Med J, 2:610-611, 1977.
19. Coxon A, Pallis CA. Metronidazole neuropathy. J Neurol Neurosurg Psychiatry, 39:403-505, 1976.
20. Lhermitte R, Fardeau M, Chedru F. Polynevrites au cours de traitements par la nitrofurantoine. Presse Med. 71:767-774, 1963.
21. Yannikas C, Pollard JD, MacLeod JG. Nitrofurantoin neuropathy. Arch Phys Med Rehabil, 11:400-405, 1981.
22. Browne MJ, Mayer KH, Chaffre SBB, Dudley MN, Posner MR et al. 2’3’didehydro-2’3’dideoxytimidine – d4T – in patients with AIDS or AIDS-related complex – a phase I trial. J Infect Dis, 167:21-29, 1993.
23. Whittington R, Brogdan RN. Zalcitabine – A review of its pharmacology and clinical potential in acquired immunodeficiency syndrome (AIDS). Drugs, 4:656-683, 1992.
24. Liebman HÁ, Cooley TP. Didanosine in treatment of AIDS or AIDS-related complex – a critical apraisal of the dose and frequency of administration. Clin Infect Dis, 16:550-558, 1993.
25. Schaumberg HH. ddC neuropathy – a study of 52 patients. Neurology, 40(suppl):428, 1990.
26. Dubinski RM. Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2’3’dideoxycytidine (ddC). Muscle Nerve, 12:856-860, 1989.
27. Katrak SM, Pollock M, O’Brien CP. Clinical and morphological features of gold neuropathy. Brain, 103:671-693, 1980.
28. Walsh JC. Gold neuropathy. Neurology, 20:455-458, 1970.
29. Masurowsky EB, Peterson ER, Crain SM. Morphologic alterations in dorsal root ganglia neurons and supporting cell of organotypic mouse spinal cord ganglion cultures exposed to Taxol. J Natl Cancer Inst, 86:18-24, 1994.
30. Guihenec P, Ginet J, Grouleau JY, Rojouan J. Early phase of vincristine neuropathy in man. J Neurol Sci, 45:355-366, 1980.
31. Casey EB, Jellefe AM, LeQuesne PM, Millett YL. Vincristine neuropathy – clinical and electrophysiological observations. Brain, 96:69-86, 1973.
32. McLeod JG, Penny R. Vincristine neuropathy – An electrophysiologic and hystological study. J Neurol Neurosur Psychiatry, 32:297-312, 1969.
33. Sahenk Z, Brady ST, Mendell JR. Studies on the pathogenesis of vincristine-induced neuropathy. Muscle Nerve, 10:80-89, 1987.
34. Ahrens EM, Meckler RJ, Callen JP. Dapsone-induced peripheral neuropathy. Int J Dermatol, 25:314-316, 1986.
35. Gutmann L, Martin JD, Welton W. Dapsone motor neuropathy – an axonal disease. Neurology, 26:514-516, 1976.
36. Roelfs RI, Hrushesky W, Rogin J, Rosenberg L. Peripheral sensory neuropathy and cisplatinum chemotherapy. Neurology, 34:934-938, 1984.
37. Riggs JE, Asharf M, Snyder RD, Gutmann L. Prospective nerve conduction studies in cisplatin therapy. Ann Neurol, 23:92-94, 1984.
38. Thompson SW, Davis LE, Kornfeldt M. Cisplatin neuropathy – clinical, electrophysiological, morphologic and toxicologic studies. Cancer, 54:1269- 127, 1984.
39. Parry GJ, Bredesen DE. Sensory neuropathy with low-dose pyridoxine. Neurology, 35:1466-1468, 1985.
40. Schaumberg H, Kaplan J, Windebrand A, Vick N, Reimuss S et al. Sensory neuropathy from pyridoxine abuse. N Engl J Med, 309:445-458, 1983.
41. Langueny A, Rommel A, Vignolli B, Taub A. Thalidomide neuropathy – an electrophysiologic study. Muscle Nerve, 9:837-844, 1986.
42. Jacobs JM, Costa-Jussá FR. The pathology of amiodarone neurotoxicity I – Experimental studies with reference to changes in other tissues. Brain, 108:735-752, 1985.
43. Jacobs JM, Costa-Jussá FR. The pathology of amiodarone neurotoxicity II – Peripheral neuropathy in man. Brain, 108:753-769, 1985.
44. Fraser AG, McQueen INF, Watt AH. Peripheral neuropathy in long term high-dose amiodarone therapy. J Neurol Neurosurg Psychiatry, 48:576-578,1985.
45. Borgeat A, deMuralt B, Stadler M. Peripheral neuropathy with high-dose ara-C therapy. Cancer, 58:852-854, 1986.

Downloads

Publicado

1999-09-30

Como Citar

Reis, R. G., & Oliveira, A. S. B. (1999). Drogas e Sistema Nervoso Periférico I: Neuropatias Tóxicas Induzidas por Drogas . Revista Neurociências, 7(3), 108–114. https://doi.org/10.34024/rnc.1999.v7.10313

Edição

Seção

Artigos Originais

Artigos mais lidos pelo mesmo(s) autor(es)

1 2 3 4 5 > >>